drugset / Trial / NCT02533362
ANF-Rho in the Treatment of Chronic Neutropenia
NaSingle-groupOpen-labelTreatment
Summary
A 6 month safety, tolerability, efficacy and pharmacokinetic study with ANF-Rho to treat patients with chronic neutropenia.
Timeline
- Start
- 2015-10
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANF-Rho | Protein / enzyme biologic | — | — |
Indications
No indication recorded.